COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,051 Articles (22,627 medRxiv, 8,424 bioRxiv)

Most recent first Previous |  Page 1090: Articles 10891-10900  | Next

Exploring the Temporal Dynamics of County-Level Vulnerability Factors on COVID-19 Outcomes
Zhang, J., Choi, D., Patel, S. A., Ho, J. C.
10.1101/2021.11.24.21266757 — Posted: 2021-11-26
COVID-19 due to the B.1.617.2 (Delta) variant compared to B.1.1.7 (Alpha) variant of SARS-CoV-2: two prospective observational cohort studies
Klaser, K., Molteni, E., Graham, M. S., Canas, L. S., Osterdahl, M. F., Antonelli, M., Chen, L., Deng, J., Murray, B., Kerfoot, E., Wolf, J., May, A., Fox, B., Capdevila Pujol, J., The COVID-19 Genomics UK (COG-UK) consortium, , Modat, M., Hammers, A., Spector, T., Steves, C., Sudre, C., Ourselin, S., Duncan, E.
10.1101/2021.11.24.21266748 — Posted: 2021-11-26 Discussion: Onsite
Germany's current COVID-19 crisis is mainly driven by the unvaccinated
Maier, B. F., Wiedermann, M., Burdinski, A., Klamser, P., Jenny, M. A., Betsch, C., Brockmann, D.
10.1101/2021.11.24.21266831 — Posted: 2021-11-26 Discussion: Onsite
Covid-19 vaccination coverage and break through infections in urban slums of Bengaluru, India: A cross sectional study.
Kumar D.R., S., J, S., Patel, A. E., R, V.
10.1101/2021.11.21.21262716 — Posted: 2021-11-26
Role of antibodies, inflammatory markers, and echocardiographic findings in post-acute cardiopulmonary symptoms after SARS-CoV-2 infection
Durstenfeld, M. S., Peluso, M. J., Kelly, J. D., Win, S., Swaminathan, S., Li, D., Arechiga, V. M., Zepeda, V., Sun, K., Shao, S., Hill, C., Arreguin, M., Lu, S., Hoh, R., Tai, V., Chenna, A., Yee, B. C., Winslow, J. W., Petropoulos, C. J., Kornak, J., Henrich, T. J., Martin, J. N., Deeks, S. G., Hsue, P. Y.
10.1101/2021.11.24.21266834 — Posted: 2021-11-26
SARS-CoV-2 vaccination predicts COVID-19 progression and outcomes in hospitalized patients
padovani, a., Cristillo, V., tomasoni, d., gipponi, s., Pilotto, A.
10.1101/2021.11.21.21266633 — Posted: 2021-11-26
SARS-CoV-2 Convalescent Sera Binding and Neutralizing Antibody Concentrations Compared with COVID-19 Vaccine Efficacy Estimates Against Symptomatic Infection
Schuh, A. J., Satheshkumar, P. S., Dietz, S., Bull-Otterson, L., Charles, M., Edens, C., Jones, J. M., Bajema, K. L., Clarke, K. E. N., McDonald, L. C., Patel, S., Cuffe, K., Thornburg, N. J., Schiffer, J., Chun, K., Bastidas, M., Fernando, M., Petropoulos, C. J., Wrin, T., Cai, S., Adcock, D., Sesok-Pizzini, D., Letovsky, S., Fry, A. M., Hall, A. J., Gundlapalli, A. V.
10.1101/2021.11.24.21266812 — Posted: 2021-11-26
Nanopore ReCappable Sequencing maps SARS-CoV-2 5' capping sites and provides new insights into the structure of sgRNAs
Ugolini, C., Mulroney, L., Leger, A., Castelli, M., Criscuolo, E., Kavanagh Williamson, M., Davidson, A. D., Almuqrin, A., Giambruno, R., Jain, M., Frige, G., Olsen, H., Tzertzinis, G., Schildkraut, I., Wulf, M. F., Correa, I. R., Ettwiller, L., Clementi, N., Clementi, M., Mancini, N., Birney, E., Akeson, M., Nicassio, F., Matthews, D. A., Leonardi, T.
10.1101/2021.11.24.469860 — Posted: 2021-11-26
Dual Effects of NV-CoV-2 Biomimetic Polymer: An Antiviral regimen against COVID-19
Chakraborty, A., Diwan, A., Chiniga, V., Arora, V., Holkar, P., Thakur, Y., Tatake, J., Barton, R., Holkar, N., Pond, B.
10.1101/2021.11.24.469813 — Posted: 2021-11-26
Synergetic measures needed to control infection waves and contain SARS-CoV-2 transmission
Su, H., Cheng, Y., Poeschl, U.
10.1101/2021.11.24.21266824 — Posted: 2021-11-25

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).